Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice

Molecular Carcinogenesis

Volumn 45, Issue 7, 2006, Pages 543-548

  Benavides, Fernando ^a   Gomes, Gregorio ^b   Venables Griffith, Ann ^a   Lambertz, Isabel ^a   Flores, Mónica ^a   Angel, Joe M ^a   Fuchs Young, Robin ^a   Richie, Ellen R ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

DMBA; MNU; SENCARB Pt; SSIN Sprd; Thymic lymphoma

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; METHYLNITROSOUREA;

ALLELIC IMBALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CARCINOGENESIS; CELL LINEAGE; CHEMICAL CARCINOGENESIS; CHROMOSOME 15; CHROMOSOME 19; CONTROLLED STUDY; DOMINANT INHERITANCE; DRUG INJECTION VOLUME; FEMALE; FLOW CYTOMETRY; GENE LOCUS; GENETIC ANALYSIS; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; INBRED STRAIN; MALE; MOLECULAR PHYLOGENY; MOUSE; MOUSE STRAIN; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; T CELL LYMPHOMA; THYMUS LYMPHOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; LYMPHOMA; METHYLNITROSOUREA; MICE; MICE, INBRED AKR; MICE, INBRED SENCAR; MICE, INBRED STRAINS; SPECIES SPECIFICITY; THYMUS NEOPLASMS;

EID: 33745685942     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20182     Document Type: Article

References (37)

1. DiGiovanni J, Slaga TJ, Boutweil RK. Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. Carcinogenesis 1980;1:381-389.
2. Fischer SM, O'Connell JF, Conti CJ, et al. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis 1987;8:421-424.
3. Hennings H, Lowry DT, Yuspa SH, Mock B, Potter M. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin. Mol Carcinog 1997;20:143-150.
4. Coghlan LG, Gimenez-Conti I, Kleiner HE, et al. Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis. Carcinogenesis 2000;21:641-646.
5. Stern MC, Conti CJ. Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Prog Clin Biol Res 1996;395:47-55.
6. Stern MC, Gimenez-Conti IB, Budunova I, et al. Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression. Carcinogenesis 1998;19:125-132.
7. Stern MC, Benavides F, LaCava M, Conti CJ. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains. Mol Carcinog 2002;35:13-20.
8. Fischer SM, Conti CJ, Locniskar M, et al. The effect of dietary fat on the rapid development of mammary tumors induced by 7,12-dimethylbenz(a) anthracene in SENCAR mice. Cancer Res 1992;52:662-666.
9. Qing WG, Conti CJ, LaBate M, Johnston D, Slaga TJ, MacLeod MC. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 1997;18: 553-559.
10. Richie ER, Angel JM, Rinchik EM. Tlag1, a novel murine tumor susceptibility gene that regulates MNU-induced thymic lymphoma development. Prog Clin Biol Res 1996;395: 23-32.
11. Herr W, Gilbert W. Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice. J Virol 1983;46:70-82.
12. Richie ER, Angel JM, Cloyd MW. Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice. J Virol 1991;65:5751-5756.
13. Angel JM, Morizot DC, Richie ER. Localization of a novel chromosome 7 locus that suppresses development of N-Methyl-N-nitrosourea-induced murine thymic lymphomas. Mol Carcinog 1993;7:151-156.
14. Stern MC, Benavides F, Klingelberger EA, Conti CJ. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression. Carcinogenesis 2000;21:1297-1301.
15. Morse HC III, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-258.
16. Richie ER, Angel JM, McEntire B. N-methyl-N-nitrosourea-induced T-lymphomas of AKR/J mice contain somatically acquired ecotropic-like murine leukemia proviruses. Virology 1988;164:211-219.
17. Stettner SL, Rummel SA, Conti CJ, Richie ER. N-methyl-N-nitrosourea alters thymocyte subset distribution and targets immature CD4-8+ cells for lymphoma development. Cancer Res 1991;51:737-740.
18. Zaidi NH, Allay E, Ayi TC, et al. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene. Carcinogenesis 1995;16:1047-1053.
19. Gomez G, Clarkin KZ, Kraig E, Infante AJ, Richie ER. TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas. Int Immunol 2000;12:263-270.
20. Benavides F, Stern MC, Glasscock E, DiGiovanni J, Coghlan LG, Conti CJ. Microsatellite DNA variants between the inbred SENCAR mouse strains. Mol Carcinog 2000;28:191-195.
21. Munro SB, Dudos AJ, Jackson AR, Baines MG, Blaschuk OW. Characterization of cadherins expressed by murine thymocytes. Cell Immunol 1996;169:309-312.
22. Hunter KW, Broman KW, Voyer TL, et al. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 2001;61:8866-8872.
23. Yoon T, Chakrabortty A, Franks R, Valli T, Kiyokawa H, Raychaudhuri P. Tumor-prone phenotype of the DDB2-deficient mice. Oncogene 2005;24:469-478.
24. Padilla O, Calvo J, Vila JM, et al. Genomic organization of the human CD8 gene. Immunogenetics 2000;51:993-1001.
25. Ochiai Y, Tamura Y, Saito Y, et al. Mapping of genetic modifiers of thymic lymphoma development in p53-knockout mice. Oncogene 2003;22:1098-1102.
26. Salvati PD, Ranford PR, Ford J, Kees UR. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. Oncogene 1995;11:1333-1338.
27. Threadgill DW, Hunter KW, Zov F, Manly KF. Genetic modifiers. In: Holland EC, editor. Mouse Models of Human Cancer, 1st edition. New York: Wiley-Liss; 2004. pp 263-291.
28. Jacoby RF, Hohman C, Marshall DJ, et al. Genetic analysis of colon cancer susceptibility in mice. Genomics 1994;22:381-387.
29. Lee GH, Bugni JM, Obata M, Nishimori H, Ogawa K, Drinkwater NR. Genetic dissection of susceptibility to murine ovarian teratomas that originate from parthenogenetic oocytes. Cancer Res 1997;57:590-593.
30. Angel JM, Richie ER. Tlag2, an -nitrosourea susceptibility locus, maps to mouse chromosome 4. Mol Carcinog 2002;33:105-112.
31. Wielowieyski A, Brennan LA, Jongstra J. Tli1, a resistance locus for carcinogen-induced T-lymphoma. Mamm Genome 1999;10:623-627.
32. Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997;17:88-91.
33. Zhang S, Ramsay ES, Mock BA. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci USA 1998;95:2429-2434.
34. Ruivenkamp CA, van Wezel T, Zanon C, et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 2002;31:295-300.
35. Ewart-Toland A, Briassouli P, de Koning JP, et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003;34:403-412.
36. Boutwell RK. Some biological aspects of skin carcinogenisis. Prog Exp Tumor Res 1964;19:207-250.
37. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992;54:63-128.